Preview
How many months of documented abstinence are required before a patient with alcoholic cirrhosis can be considered for liver transplantation? What is the role of liver transplantation as treatment for primary hepatocellular cancer? What are the possible causes of elevated liver enzyme levels following transplantation? Which patients with neurologic injury are potential organ donors? The authors answer these and other questions primary care physicians may have about this lifesaving procedure.
Additional information
Notes on contributors
Charles F. Gholson
Charles F. Gholson, MD John McDonald, MD Robert McMillan, MD Dr Gholson (not pictured) is associate professor of medicine, division of gastroenterology; Dr McDonald (left) is professor and chairman, department of surgery; and Dr McMillan (right) is assistant professor and director of liver transplantation, department of surgery, Louisiana State University School of Medicine in Shreveport.
John McDonald
Charles F. Gholson, MD John McDonald, MD Robert McMillan, MD Dr Gholson (not pictured) is associate professor of medicine, division of gastroenterology; Dr McDonald (left) is professor and chairman, department of surgery; and Dr McMillan (right) is assistant professor and director of liver transplantation, department of surgery, Louisiana State University School of Medicine in Shreveport.
Robert McMillan
Charles F. Gholson, MD John McDonald, MD Robert McMillan, MD Dr Gholson (not pictured) is associate professor of medicine, division of gastroenterology; Dr McDonald (left) is professor and chairman, department of surgery; and Dr McMillan (right) is assistant professor and director of liver transplantation, department of surgery, Louisiana State University School of Medicine in Shreveport.